Innoviva, Inc. (INVA)
NASDAQ: INVA · Real-Time Price · USD
21.24
+0.07 (0.33%)
At close: Aug 26, 2026, 4:00 PM EDT
21.24
0.00 (0.00%)
Pre-market: Aug 27, 2026, 4:37 AM EDT
Innoviva Employees
Innoviva had 159 employees as of December 31, 2025. The number of employees increased by 32 or 25.20% compared to the previous year.
Employees
159
Change (1Y)
32
Growth (1Y)
25.20%
Revenue / Employee
$2,767,283
Profits / Employee
$2,246,767
Market Cap
1.53B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Ascentage Pharma Group International | 767 |
| Novavax | 749 |
| Replimune Group | 465 |
| Cullinan Therapeutics | 109 |
| Tyra Biosciences | 87 |
| ArriVent BioPharma | 77 |
| Apnimed | 65 |
INVA News
- 10 days ago - Innoviva management to meet virtually with Cantor Fitzgerald - TheFly
- 15 days ago - Innoviva Specialty Therapeutics' Antimicrobial Therapies, XACDURO®, ZEVTERA® and NUZOLVENCE® Designated Finalists for the 2026 Prix Galien USA Best Pharmaceutical Product Award - Business Wire
- 19 days ago - Innoviva price target lowered to $34 from $36 at Cantor Fitzgerald - TheFly
- 21 days ago - Innoviva reports Q2 EPS ($1.14), consensus 49c - TheFly
- 21 days ago - Innoviva Reports Second Quarter 2026 Financial Results; Highlights Recent Company Progress - Business Wire
- 21 days ago - Innoviva Quarterly report: Q2 2026 - Filings
- 21 days ago - Innoviva Earnings release: Q2 2026 - Filings
- 2 months ago - Innoviva’s Nortiva Bio launches to develop long-acting oral medicines - TheFly